Affiliation:
1. Department of Rheumatology, Covina Arthritis Clinic, 500 West San Bernadino Rd, Suite A, United States
Abstract
Abstract:
Fibromyalgia (FM) is a complex, widespread pain disorder characterized by symptoms
such as fatigue, sleep deprivation, mental fog, mood swings, and headaches. Currently, there are
only three FDA-approved medications for FM patients: duloxetine, milnacipran, and pregabalin,
with outcomes frequently being inadequate.
This research team aims to investigate the effects of diet and lifestyle modifications on FM, with
emphasis on anti-inflammatory diet, antioxidants, and gluten-free diets, as well as supplementation
with Magnesium, CQ10, and Vitamin D, microbiome, sleep, exercise, and cognitive behavioral
therapy. We reviewed the pathophysiology of certain foods that can be proinflammatory with
the release of cytokines leading to activation of pain, fatigue and aggravation of the majority of Fibromyalgia
symptoms. A literature review was performed by identifying FM articles published between
1994 and 2022 via PubMed and EMBASE databases, with particular emphasis on randomized
controlled trials, meta-analysis, and evidence-based treatment guidelines. This review article
was completed by a comprehensive narrative review process, in which our team systematically
examined relevant scientific literature to provide a comprehensive overview of the significant
role that diet and other lifestyle modifications play in mediating symptoms of Fibromyalgia.
We propose that diet modifications and lifestyle changes, such as sleep, exercise, and weight loss,
can be important steps in managing FM.
Publisher
Bentham Science Publishers Ltd.
Reference95 articles.
1. Bellato E.; Marini E.; Castoldi F.; Barbasetti N.; Mattei L.; Bonasia D.E.; Blonna D.; Fibromyalgia syndrome: Etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012,2012,1-17
2. Siracusa R.; Paola R.D.; Cuzzocrea S.; Impellizzeri D.; Fibromyalgia: Pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 2021,22(8),3891
3. Duque L.; Fricchione G.; Fibromyalgia and its new lessons for neuropsychiatry. Med Sci Monit Basic Res 2019,25,169-178
4. Bartels E.M.; Dreyer L.; Jacobsen S.; Jespersen A.; Bliddal H.; Danneskiold-Samsøe B.; Fibromyalgia, diagnosis and prevalence. Are gender differences explainable?. Ugeskr Laeger 2009,171(49),3588-3592
5. Häuser W.; Petzke F.; Sommer C.; Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 2010,11(6),505-521